Natural Capsules Ltd.

₹165.75

2.4 (1.5%)

NATCAPSUQ Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 171 Cr

P/E Ratio277.64

Dividend YieldN/A

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	167.17	Bearish
10-DMA	172.99	Bearish
20-DMA	178.28	Bearish
50-DMA	181.22	Bearish
100-DMA	201.07	Bearish
200-DMA	207.84	Bearish

Historical Performance

1 Year

N/A

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	1,692	1,554	1,724	1,351	795
Total Expenditure	1,516	1,370	1,381	1,108	684
Other Income	8	36	16	22	7
Operating Profit	184	220	359	265	118
Interest	65	53	37	21	5
Depreciation	91	87	72	50	43
Profit Before Tax	28	81	250	194	92
Consolidated Net Profit	6	56	184	137	68
Adjusted EPS	1	6	20	20	9

Compounded Sales Growth

10 Years:25.3

5 Years:22.4

3 Years:4.6

TTM:1.7

Compounded Profit Growth

10 Years:-11.1

5 Years:-6.4

3 Years:-46.2

TTM:-35.6

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:N/A

Return on Equity

10 Years:N/A

5 Years:9

3 Years:19.9

last year:0.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	103	93	93	70	62
Total Reserves	2,222	1,944	1,140	760	559
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	622	712	736	365	15
Other Current Liabilities	236	146	153	110	67
Short Term Borrowings	369	300	220	163	96
Total Liabilities	4,194	3,765	2,888	1,643	970
Capital Work in Progress	---	1,438	877	201	70
Long Term Loans & Advances	26	25	22	16	15
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	353	360	328	357	140
Total Current Assets	1,296	1,238	1,015	756	497
Total Assets	4,194	3,765	2,888	1,643	970
Adjusted Book Value	225	218	133	118	82

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 277.64, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered price CAGR data is unavailable.
The stock carries a low beta of 0.1, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹184 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1692 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 664195.6

No. of Shares: 4007 (Approx)

Performance:-33.6%

P/L: ₹-335804.4

NIFTY Performance: 9.4%

1 day Top Gainers